ospe 21 march 2017

62
Objective Structured Practical Examination Prof Md ANISUR RAHMAN PROF & HEAD OF THE DEPARTMENT (OPHTHALMOLOGY) DHAKA MEDICAL COLLEGE. DHAKA

Upload: anisur-rahman

Post on 21-Apr-2017

80 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Ospe 21 march 2017

Objective Structured Practical Examination

Prof Md ANISUR RAHMANPROF & HEAD OF THE DEPARTMENT

(OPHTHALMOLOGY)DHAKA MEDICAL COLLEGE. DHAKA

Page 2: Ospe 21 march 2017

OSPE: 1A 20 year old student complaints frequent changes of

his spectacles for last 5 year with progressive

unsatisfactory visual outcome. Now his BCVA in R/E

6/12 with – 3.00 DS / - 4.50 DC 20 & L/E 6/36 with –

5.00 DS / - 7.50 DC 140. About 10 years back his

vision was 6/6 in both eyes.

Page 3: Ospe 21 march 2017

1) What is your diagnosis?

2) Enumerate 2 differential diagnosis

3) Mention 4 signs with name of used instruments

4) Mention 2 clinical tests for confirming the diagnosis

Page 4: Ospe 21 march 2017

This OSPE question was made by a cornea specialist

but the answer key was wrong

Page 5: Ospe 21 march 2017

1) Keratoconus 2

2) D/D (any two) 1 x 2 = 2

– Keratoglobus

– Refractive error

– Pellucid Marginal Degeneration

Page 6: Ospe 21 march 2017

3) Signs (Any 4) (0.5 x 2 x 4= 4)– Direct ophthalmoscope- oil droplet reflex– Retinoscope – scissors reflex– Slit lamp – Vogt striae & Fleischer ring– Torch - Rizuti sign

Page 7: Ospe 21 march 2017

Clinical investigations (any two) 1 x 2

– Corneal topography

– Pantacam

– Pachymetry

Page 8: Ospe 21 march 2017

OSPE: 2Supplied vial containing 500 mg of Inj. Ceftazidime.

Make 0.2 mg in 0.1 ml preparation with supplied

materials for intravitreal injection. (with commentary)

Page 9: Ospe 21 march 2017

• FOLLOWING THINGS ARE NEEDED 

a. Inj Ceftazidime 500mg vial

b. Gloves

c. 5 ml syringe

d. 1 ml syringe

e. Water for injection

Page 10: Ospe 21 march 2017

1 Wearing of the gloves

2 Add 5mL water for injection with 5 cc

syringe

3 Mixing with shaking

4 Take 1 ml & add 4 ml of D/W

Page 11: Ospe 21 march 2017

5 Mixing with shaking

6 Take 0.1 ml in tuberculin syringe

7 Discard disposable into basket

8 De-wearing of gloves

Page 12: Ospe 21 march 2017

OSPE: 3. Which of the following series correctly depicts the relative duration of drug action?

1) atropine>homatropine>scopolamine>cyclopentolate

>tropicamide

2) atropine>scopolamine>homatropine>cyclopentolate

>tropicamide

3) cyclopentolate>tropicamide>scopolamine>homatrop

ine>atropine

Page 13: Ospe 21 march 2017

4)homatropine>cyclopentolate>tropicamide>scopolami

ne>atropine

5)homatropine>atropine>scopolamine>cyclopentolate>t

ropicamide

Page 14: Ospe 21 march 2017

Answer is: b.

The duration of action of atropine is 7-14 days,

scopolamine is 4-7 days, homatropine is 3 days,

cyclopentolate is 2 days, and tropicamide is 4-6

hours.

(source: AAO Vol: 2. Page: 413)

Page 15: Ospe 21 march 2017

Q.1. What are the pictures of?

Q.2. What is the possible diagnosis?

Q.3. Write down 3 associated findings.

Q: 4. What is about VA?

Page 16: Ospe 21 march 2017

Q.1. What are the pictures of?

A: Iris transillumination defect

Q.2. What is the possible diagnosis?

A: Albinism

Q.3. Write down 3 associated findings / signsA: Nystagmus Foveal hypoplasia Hypopigmentation of fundus High refractive error AmblyopiaQ: 4 < 6/60

Page 17: Ospe 21 march 2017

On performing fundus biomicroscopy, this was seen.

OSPE: 5

Page 18: Ospe 21 march 2017

Q.1. What is it?

Q. 2 What may be the early symptom? Mention one

Q.3. What is the diagnosis?

Q.4. Write down 2 causes?

Page 19: Ospe 21 march 2017

Q.1. What is it? A: Weiss ring

Q.2. What is the diagnosis? A: Post vit detachment

Q.3. Write down 2 causes? A: Trauma, Myopia, Old age

Page 20: Ospe 21 march 2017

OSPE: 6. H/O DOUBLE VISION

1) Greetings & self introduction------------------ 0.25 +

0.25= 0.50

2) Whether double vision is monocular or binocular.--

0.50

3) Direction of double vision: whether the diplopia is

horizontal, vertical or torsional.

Page 21: Ospe 21 march 2017

4) Ask the patient in which direction of gaze the

diplopia is worse→ right, left, up, down, right and

up, right and down, left and up, left and down, or

distance or near.

5) Ask for diurnal variability and fatigability of

diplopia

Page 22: Ospe 21 march 2017

6) Detailed history about :

• mode of onset,

• duration of onset,

• associated pain,

• history of strabismus in childhood,

Page 23: Ospe 21 march 2017

7) history of trauma,

8) neurological symptoms such as dysphagia or

weakness,

9) Underlying systemic illness:

a. hypertension,

b. diabetes,

Page 24: Ospe 21 march 2017

10)cerebrovascular disease,

11) cardiac atherosclerotic disease

12)multiple sclerosis.

13)History of smoking or alcohol intake should be

elicited.

Page 25: Ospe 21 march 2017

OSPE: 7. OCTThis is OCT macular protocol of a 30 years old man

who came with the complaint of blurred vision for 2

weeks.

Page 26: Ospe 21 march 2017
Page 27: Ospe 21 march 2017

1) What is the positive findings here?

2) What is your diagnosis?

3) What is its basic mechanism?

4) Write 2 treatment options.

5) Write 2 natural course

Page 28: Ospe 21 march 2017

A

Separation of RPE from bruchs membrane

An optically empty space in between them.

B. Serous PED

C. Reduction of hydraulic conductivity of a thickened

& dysfunctional bruchs membrane.

Page 29: Ospe 21 march 2017

D.

• Any two

i. Observation

ii. Intra vitreal Anti-VEGF

iii. Combined Anti-VEGF & PDT.

Page 30: Ospe 21 march 2017

E. Any two

i. Persistence with atrophy & decrease vision

ii. Resolution with geographical atrophy with visual

loss

iii. RPE tear

iv. Develop CNV in 1/3rd eye.

Page 31: Ospe 21 march 2017

OSPE: 8A man of 55 year old is in service, came to you with

the complaints of progressive dimness of vision right

eye for last 2 year. On examination you found that he

is suffering from grade 3 Age related cataract right

eye visual acuity is 6/60. Left eye is aphakic and his

BCVA of left eye if 6/12 N6.Now you have to counsel

him regarding his treatment plan.

Page 32: Ospe 21 march 2017

01 Greetings02 Explanation of cataract surgery also

complication03 If we do phaco surgery then you will face some

problem3a Left eye will be inactive3b If you use the current glass double

vision

Page 33: Ospe 21 march 2017

4 You have few option for L/E4 A Secondary implant of IOL in A/C4 B Secondary implant of IOL by scleral fixation4 C You can use Contact lens in L/E

Page 34: Ospe 21 march 2017

5 ABOUT RIGHT EYE5A R/E will be also Aphakia 5B If Aphakia we need this sort of glass in R/E also5C For the glass the image size will be bigger5D Weight of the glass can make you unhappy6 Any feedback from patient7 Thank’s to the patient

Page 35: Ospe 21 march 2017

OSPE: 9.Scenario & Question

A 28-year-old obese woman complains of transient

visual loss lasting seconds in the right eye when

rising from a bent position. Examination reveals

normal acuity OU with bilateral disc edema.

Page 36: Ospe 21 march 2017

QUESTION

1) What may be the cause?

2) What investigation you prefer? And why? Mention

one

3) What history you should take? Mention one

4) What is the long-term visual prognosis?

Page 37: Ospe 21 march 2017

Answer1) Idiopathic intracranial hypertension, (previously known as

benign intracranial hypertension or pseudotumor cerebri).

2) MRI of the brain. To exclude ICSOL

3) Drug history.

4) In 75% cases visual outcome is good. But in 25% cases

permanent impairment of vision

Page 38: Ospe 21 march 2017

OSPE: 10. Scenario A boy of 10 year came to you with rapid swelling of the right

eye associated with pain exacerbated by eye movement,

visual impairment and double vision. He has also given history

of flu like symptoms for the last 5 days.

O/E Tender, firm, erythematous and warm eyelids, with

periocular and conjunctival (chemosis) oedema. There is also

reduced VA and impairment of colour vision

Page 39: Ospe 21 march 2017

Question

1) What is your provisional diagnosis?

2) What might be the cause? Mention 3.

3) Mention 3 D/D.

4) Why impairment of colour vision?

Page 40: Ospe 21 march 2017

Answer

1) Bacterial orbital cellulitis

2) Streptococcus pneumoniae, Staphylococcus aureus,

Streptococcus pyogenes and Haemophilus

influenzae. (any 3)

3) Fungal orbital infection. Acute dacryocystitis. Acute

orbital haemorrhage.

Page 41: Ospe 21 march 2017

OSPE: 11. Scenario

It is a diseases of diagnosis of exclusion and should

be investigated fully. Orbit & peri orbital region is

affected

Presentation is with ipsilateral periorbital or

hemicranial pain, and diplopia due to one or more

ocular motor pareses, with pupillary and eyelid

involvement in many cases. Proptosis, if present, is

usually mild.

Page 42: Ospe 21 march 2017

Question

1) What is your probable diagnosis?

2) What type of disease is this?

3) What is the line of treatment? Mention 2.

4) What is the prognosis?

Page 43: Ospe 21 march 2017

Answer

1) Tolosa-Hunt syndrome.

2) Granulomatous disease

3) Systemic steroids and other immunosuppressants as

necessary;

4) The clinical course is characterized by remissions

and recurrences.

Page 44: Ospe 21 march 2017

12. Pain that persists for more than one month after other sings and symptoms disappear

1) What is the probable diagnosis?

2) Which age group is more sufferer?

3) What are the characteristic of pain? Mention 3

4) Why some of the patient suffered from depression?

5) What is the most devastating even life-threatening

condition

6) What are the local treatment? Mention 2

Page 45: Ospe 21 march 2017

Answer

1) Post-herpetic neuralgia

2) Above 70 year.

3) Pain may be constant or intermittent, worse at night

and aggravated by minor stimuli, touch and heat

4) Neuralgia can impair the QOL, and may lead to

depression.

Page 46: Ospe 21 march 2017

5) Patient may committed suicide.

6)

Local Cold compresses.

Topical capsaicin 0.075%

lidocaine 5% patches.

Page 47: Ospe 21 march 2017

13 A patient of 30 year old known case of RP. Now counsel the patient regarding treatment and future plan

1 Glass prescription

2 LVA

3 Field expander

4 Cataract surgery if required

5 Treatment of CMO with acetazolamide

Page 48: Ospe 21 march 2017

6 Advice ocular examination of other family

member

7 Address other associated systemic problems

8 Genetic counseling

9 Rehabilitation

10 Information regarding any new scientific

development

Page 49: Ospe 21 march 2017

14 Give a list of what instruments and device you keep ready in a FFA room for schedule and tackle the emergency

1) Emesis basin

2) Oxygen

3) Sphygmomanometer and stethoscope

4) Couch for patient to lie down

5) Ice pack

6) Tourniquet

7) Disposable needles

Page 50: Ospe 21 march 2017

8) Disposable syringes

9) IV set and scalp vein set

10) Airway device

11) Ambu bag

12) Ing Adrenaline

13) Inj atropine

14) Inj Avil.

Page 51: Ospe 21 march 2017

15) Inj Betnesol

16) Inj Decadron

17) Inj Deriphylline

18) Inj Dextrose 5%

19) Inj Dextrose 25%

20) Inj Dextrose 50%

Page 52: Ospe 21 march 2017

OSPE: 15

The device is used to correct emmetropia. What is it?

Page 53: Ospe 21 march 2017

ANSWER

Is an intracorneal ring which is used to flatten the

cornea and reduces refractive error.

Page 54: Ospe 21 march 2017

Figure 1Slit-lamp photo of the right eye showing an area of 90% thinning peripherally, extending from the 6:00 to the 1:00 o'clock position. Neovascular changes within the furrow are present with an intact epithelium and a leading edge of lipid deposition anteriorly. The left eye showed similar but much milder changes with a 10% thinning over a three clock hour area.

Page 55: Ospe 21 march 2017

Examination Vision: CF at 4 ft OD ph 20/200; 20/30 OS ph 20/20 .

Pupils: Normal OU, No APD .

Slit lamp examination: See Figure 1.

Applanation Tonometry: 15 mmHg OU .

Fundus examination: Normal OU .

Corneal Topography: See Figure 2

Page 56: Ospe 21 march 2017

Question1) What is your diagnosis?2) What is the male female ratio of the disease?3) Which portion of the cornea it starts from?4) What type of astigmatism is there?5) What are the potentially sight threatening

complications in this disorder?6) How would you manage this condition in early and

late stages?

Page 57: Ospe 21 march 2017

Answer

1) Terrien's marginal corneal degeneration.

2) Male : Female 3:1.

3) Superonasal portion of the cornea,

4) Against the rule astigmatism.

5) Spontaneous perforation or perforation due to minor

trauma occurs in approximately 15% of patients.

Page 58: Ospe 21 march 2017

06) In early stage, spectacle or RGP or Piggy bag

contact lens. In late stage, Surgery, involving either

crescent-shaped excision of the gutter with suturing

of the margins or peripheral lamellar transplantation,

gives variable results.

Page 59: Ospe 21 march 2017

OSPE: 17

A 60 years old male patient having uneventful

phacoemulsification with PC- IOL implantation under

topical anesthesia in his right eye. Prepare a discharge

certificate for the patient.

Page 60: Ospe 21 march 2017

PARAMETER MARKS1) Identification of the patient

Name 0.5Age 0.25Gender 0.25Address 0.5Mobile No 0.25

Page 61: Ospe 21 march 2017

2) Operation note

Date & time 0.5Name of surgery 0.5Name of anesthesia 0.5Name of surgeon 0.5

3) Post-operative findings

Visual acuity 1Anterior segment 1Posterior segment 0.5

Page 62: Ospe 21 march 2017

03 Advice No water to eyeUse dark glassRegular use of medicineAny problem come to doctorFollow up

04) Identification of certificate preparatory

Signature with dateName of the doctor with designationSeal of the department